Though, increased FDG uptake may be seen in both benign and malignant thyroid conditions, there is difference in the expression of hypoxia-related GLUT1 and GLUT3 between benign and malignant neoplasms, as well as non-neoplastic thyroid lesions. This evidence concerns the gene SLC2A3 and cancer.